Quick Answer
LeonaBio, Inc. reported Operating Income of -$102.27 million for fiscal year 2025.
LeonaBio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$102.27M | -1.4% |
| 2024 | -$100.90M | +19.6% |
| 2023 | -$125.47M | -20.6% |
| 2022 | -$104.02M | -62.5% |
| 2021 | -$64.02M | -220.2% |
| 2020 | -$20.00M | -266.9% |
| 2019 | -$5.45M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.87M | +76.8% | +5.7% |
| June 30, 2025 | -$7.29M | +74.0% | +23.5% |
| March 31, 2025 | -$9.54M | +65.6% | +67.8% |
| September 30, 2024 | -$29.62M | +15.5% | -5.7% |
| June 30, 2024 | -$28.03M | +11.4% | -1.2% |
| March 31, 2024 | -$27.69M | +7.0% | +21.0% |
| September 30, 2023 | -$35.04M | -45.2% | -10.8% |
| June 30, 2023 | -$31.64M | -34.2% | -6.3% |
- LeonaBio, Inc. showed a decrease of -1.4% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, LeonaBio, Inc.’s operating income has declined by 1776.8% (from -$5.45 million to -$102.27 million).
- The most recent figure is from LeonaBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: